#Toronto #Life Sciences #ACTO Technologies #AI Superagents

ACTO Launches Groundbreaking Role-Based AI SuperAgents

In a significant advancement for the life sciences sector, ACTO has introduced its revolutionary AI SuperAgents, a unique solution designed to enhance the efficiency of customer-facing professionals. The company aims to merge human intelligence with empathetic AI to redefine how these professionals operate.

Traditionally, many AI solutions available in the market tend to focus on individual tasks or workflows, which often results in isolated applications that complicate rather than simplify the workflow for professionals. ACTO SuperAgents break this mold by being specifically tailored to employee roles, supporting workers with intelligent and context-aware assistance.

Introducing ACTO SuperAgents

ACTO’s SuperAgents reconfigure the way AI services benefit the life sciences industry—not as a disparate collection of tools, but as a cohesive, human-centered multipliers of productivity. The need for an intelligent solution has grown as companies in the life sciences industry face increasing pressure to do more with fewer resources. The approach taken by ACTO directly addresses this challenge by offering a fundamentally new kind of role-based AI agent that collaborates with users, as opposed to simply functioning within automated systems.

According to Parth Khanna, CEO of ACTO, “We are standing at a critical juncture of technological innovation. AI is already transforming drug discovery, drastically reducing development timelines and accelerating the launch of new therapies. Our goal is to carry this momentum into the post-approval phase by equipping customer-facing teams with role-based SuperAgents, automating workflows, and freeing up more time to collaborate with healthcare providers.